{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:11:11Z","timestamp":1791897071737,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.euo.2023.10.028","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T01:06:38Z","timestamp":1700269598000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5219-2978","authenticated-orcid":false,"given":"Amanda A.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth P.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim A.","family":"Touijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9928","authenticated-orcid":false,"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.10.028_b0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-5347(17)52740-8","article-title":"Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference","volume":"128","author":"Skinner","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0010","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3390\/cancers15112951","article-title":"Assessing the performance of 18F-FDG PET\/CT in bladder cancer: a narrative review of current evidence","volume":"15","author":"Bacchiani","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2023.10.028_b0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00345-018-2439-8","article-title":"Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis","volume":"37","author":"Crozier","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.eururo.2009.10.026","article-title":"A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder","volume":"57","author":"Roth","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0025","doi-asserted-by":"crossref","first-page":"307.e309","DOI":"10.1016\/j.urolonc.2018.03.002","article-title":"Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer","volume":"36","author":"Moschini","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0030","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/01.ju.0000121604.58067.95","article-title":"Stage specific lymph node metastasis mapping in radical cystectomy specimens","volume":"171","author":"Vazina","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial","volume":"75","author":"Gschwend","year":"2019","journal-title":"Eur Urol"},{"issue":"16_suppl","key":"10.1016\/j.euo.2023.10.028_b0040","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2023.41.16_suppl.4508","article-title":"SWOG S1011: a phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer","volume":"41","author":"Lerner","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.986150","article-title":"Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis","volume":"12","author":"Qi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12957-019-1759-5","article-title":"Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes","volume":"17","author":"Wang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0055","unstructured":"NCCN. Clinical practice guidelines in oncology. Plymouth Meeting, PA: National Comprehensive Cancer Network. https:\/\/www.nccn.org\/guidelines\/."},{"key":"10.1016\/j.euo.2023.10.028_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1200\/JCO.2007.12.9247","article-title":"Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC","volume":"26","author":"Kassouf","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0065","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/iju.14974","article-title":"Relationship between the number of lymph nodes dissected and prognosis in muscle-invasive bladder cancer in the era of neoadjuvant chemotherapy","volume":"29","author":"Tochigi","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0070","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ejso.2018.12.004","article-title":"Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma","volume":"45","author":"Nazzani","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/2090598X.2020.1791563","article-title":"Lymph node dissection for upper tract urothelial carcinoma: a systematic review","volume":"19","author":"Chan","year":"2020","journal-title":"Arab J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.euf.2017.09.015","article-title":"Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer","volume":"5","author":"Dominguez-Escrig","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.10.028_b0090","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.juro.2015.06.077","article-title":"Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates","volume":"194","author":"Matin","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/iju.12338","article-title":"Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study","volume":"21","author":"Kondo","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1089\/end.2022.0103","article-title":"Oncological outcomes of retroperitoneal lymph node dissection during retroperitoneal laparoscopic radical nephroureterectomy for renal pelvic or upper ureteral tumors: matched-pair analysis","volume":"36","author":"Kanno","year":"2022","journal-title":"J Endourol"},{"key":"10.1016\/j.euo.2023.10.028_b0105","doi-asserted-by":"crossref","first-page":"1115830","DOI":"10.3389\/fonc.2023.1115830","article-title":"Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort study","volume":"13","author":"Cui","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0110","doi-asserted-by":"crossref","first-page":"33.e21","DOI":"10.1016\/j.urolonc.2016.07.022","article-title":"External validation of the pathological nodal staging score in upper tract urothelial carcinoma: a population-based study","volume":"35","author":"Xylinas","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","article-title":"Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881","volume":"55","author":"Blom","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bju.14127","article-title":"The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis","volume":"121","author":"Bhindi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.10.028_b0125","article-title":"The role of lymph node dissection for non-metastatic renal cell carcinoma: an updated systematic review and meta-analysis","volume":"11","author":"Shi","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0130","doi-asserted-by":"crossref","first-page":"293.e225","DOI":"10.1016\/j.urolonc.2019.01.009","article-title":"The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy","volume":"37","author":"Capogrosso","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2010.08.042","article-title":"Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates","volume":"59","author":"Crispen","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajur.2019.06.004","article-title":"Survival benefit with extended lymphadenectomy for advanced renal malignancy: a population-based analysis","volume":"7","author":"Laganosky","year":"2020","journal-title":"Asian J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0145","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00345-023-04413-z","article-title":"Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy","volume":"41","author":"Rosiello","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0150","doi-asserted-by":"crossref","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","article-title":"Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival","volume":"4","author":"Dudani","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.euo.2023.10.028_b0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.urolonc.2020.01.013","article-title":"Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma","volume":"38","author":"Rosiello","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","article-title":"Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.eururo.2020.03.023","article-title":"External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection","volume":"78","author":"Gandaglia","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0175","doi-asserted-by":"crossref","unstructured":"Gandaglia G, Barletta F, Robesti D, et al. Identification of the optimal candidates for nodal staging with extended pelvic lymph node dissection among prostate cancer patients who underwent preoperative prostate-specific membrane antigen positron emission tomography. External validation of the Memorial Sloan Kettering Cancer Center and Briganti nomograms and development of a novel tool. Eur Urol Oncol. 2023;6(6):543\u2013552.","DOI":"10.1016\/j.euo.2023.05.003"},{"key":"10.1016\/j.euo.2023.10.028_b0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0185","unstructured":"EAU. EAU guidelines. Presented at: The 38th Annual EAU Congress; March 10\u201313, 2023; Milan."},{"key":"10.1016\/j.euo.2023.10.028_b0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0195","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0200","first-page":"262","article-title":"Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis","volume":"71","author":"Garc\u00eda-Perdomo","year":"2018","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euo.2021.08.001","volume":"5","author":"Stabile","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2021.05.006","article-title":"External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study","volume":"80","author":"Meijer","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0215","doi-asserted-by":"crossref","unstructured":"Nguyen HG, van den Berg NS, Antaris AL, et al. First-in-human evaluation of a prostate-specific membrane antigen-targeted near-infrared fluorescent small molecule for fluorescence-based identification of prostate cancer in patients with high-risk prostate cancer undergoing robotic-assisted prostatectomy. Eur Urol Oncol. 2024;7:63\u201372.","DOI":"10.1016\/j.euo.2023.07.004"},{"key":"10.1016\/j.euo.2023.10.028_b0220","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00345-023-04396-x","article-title":"Outcomes following radical inguinal lymphadenectomy for penile cancer using a fascial-sparing surgical technique","volume":"41","author":"Schifano","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0225","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.juro.2017.06.076","article-title":"Delay to inguinal lymph node dissection greater than 3 months predicts poorer recurrence-free survival for patients with penile cancer","volume":"198","author":"Chipollini","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0230","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0235","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/JU.0000000000001775","article-title":"Clinical outcomes in clinical N0 squamous cell carcinoma of the penis according to nodal management: early, delayed or selective (following dynamic sentinel node biopsy) inguinal lymph-node dissection","volume":"206","author":"Nazzani","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0240","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-5347(17)41589-8","article-title":"Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results","volume":"140","author":"Catalona","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bju.14883","article-title":"Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection","volume":"125","author":"Chipollini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.10.028_b0250","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.juro.2014.12.019","article-title":"Prophylactic pelvic lymph node dissection in patients with penile cancer","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0255","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","article-title":"The International Penile Advanced Cancer Trial (InPACT): rationale and current status","volume":"5","author":"Canter","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.10.028_b0260","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2020.09.007","article-title":"Hybrid indocyanine green\u201399mTc-nanocolloid for single-photon emission computed tomography and combined radio- and fluorescence-guided sentinel node biopsy in penile cancer: results of 740 inguinal basins assessed at a single institution","volume":"78","author":"Dell\u2019Oglio","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0265","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.euf.2022.11.018","article-title":"Diagnostic accuracy of dynamic sentinel lymph node biopsy for penile cancer: a systematic review and meta-analysis","volume":"9","author":"Fallara","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.10.028_b0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.euo.2020.08.007","article-title":"Long-term surveillance of patients with complete response following chemotherapy for metastatic nonseminomatous germ cell tumor","volume":"4","author":"Nason","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2022.12.032","volume":"182","author":"Antonelli","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2023.10.028_b0280","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1200\/JCO.18.01250","article-title":"Treatment of relapse of clinical stage I nonseminomatous germ cell tumors on surveillance","volume":"37","author":"Hamilton","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0285","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1200\/JCO.22.00624","article-title":"Surgery in early metastatic seminoma: a phase II trial of retroperitoneal lymph node dissection for testicular seminoma with limited retroperitoneal lymphadenopathy","volume":"41","author":"Daneshmand","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.028_b0290","doi-asserted-by":"crossref","unstructured":"Heidenreich A, Paffenholz P, Hartmann F, Seelemeyer F, Pfister D. Retroperitoneal lymph node dissection in clinical stage IIA\/B metastatic seminoma: results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS). Eur Urol Oncol. 2024;7:122\u2013127.","DOI":"10.1016\/j.euo.2023.06.004"},{"key":"10.1016\/j.euo.2023.10.028_b0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eururo.2022.10.021","article-title":"Phase 2 single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA\/B (PRIMETEST)","volume":"84","author":"Hiester","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.028_b0300","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1200\/JCO.22.01822","article-title":"Primary retroperitoneal lymph node dissection for stage II seminoma: is surgery the new path forward?","volume":"41","author":"Tachibana","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T01:24:55Z","timestamp":1715822695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2588931123002456"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.10.028","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}